Growth hormone (GH)-deficient men are more responsive to GH replacement therapy than women

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 2, 1997, Pages 550-555

  Burman, Pia ^a   Johansson, Anna G ^b   Siegbahn, Agneta ^a   Vessby, Bengt ^a   Karlsson, F Anders ^b  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; CHOLESTEROL; HUMAN GROWTH HORMONE; OSTEOCALCIN; PROCOLLAGEN; SOMATOMEDIN C;

ADULT; ARTICLE; BONE DEVELOPMENT; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; GROWTH REGULATION; HUMAN; LEAN BODY WEIGHT; MALE; OSTEOLYSIS; PRIORITY JOURNAL; SEX DIFFERENCE;

ADULT; BLOOD COAGULATION FACTORS; BODY COMPOSITION; BODY WEIGHT; BONE AND BONES; DOUBLE-BLIND METHOD; FEMALE; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LIPIDS; LIPOPROTEINS; MALE; METABOLISM, INBORN ERRORS; MIDDLE AGED; RECOMBINANT PROTEINS; SEX CHARACTERISTICS; TREATMENT OUTCOME;

EID: 0031027955     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.2.550     Document Type: Article

References (47)

1. De Boer H, Blok GJ, Van der Veen E. 1995 Clinical aspects of growth hormone deficiency in adults. Endocr Rev. 16:63-86.
2. Rosén T, Bengtsson B-Å. 1990 Premature mortality due to cardiovascular disease in hypopituitarism. Lancet. 336:285-288.
3. Jørgensen JOL, Pedersen SA, Thuessen L, et al. 1989 Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet. 1:1221-1225.
4. Salomon F, Cuneo RC, Hesp R, Sönksen PH. 1989 The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med. 321:1797-1803.
5. Whitehead HM, Boreham C, Mcllrath EM, et al. 1992 Growth hormone treatment of adults with growth hormone deficiency: results of 13-month placebo controlled cross-over study. Clin Endocrinol (Oxf). 36:45-52.
6. Bengtsson B-Å, Edén S, Lönn L, et al. 1993 Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J Clin Endocrinol Metab. 76:309-317.
7. Cuneo RC, Salomon F, Watts GF, Hesp R, Sönksen P. 1993 Growth hormone treatment improves serum lipids and lipoproteins in adults with growth hormone deficiency. Metabolism. 42:1519-1523.
8. Degerblad M, Elgindy N, Hall K, Sjöberg H-E, Thorén M. 1992 Potent effect of recombinant growth hormone on bone mineral density and body composition in adults with panhypopituitarism. Acta Endocrinol (Copenh). 126:387-393.
9. Russel-Jones DL, Watts GF, Weissberger A, et al. 1994 The effect of growth hormone replacement on serum lipids, lipoproteins, apolipoproteins and cholesterol precursors in adult growth hormone deficient patients. Clin Endocrinol (Oxf). 41:345-350.
10. Beshyah SA, Henderson A, Niththyananthan R, et al. 1995 The effects of short and longterm growth hormone replacement therapy in hypopituitary adults on lipid metabolism and carbohydrate tolerance. J Clin Endocrinol Metab. 80:356-363.
11. Beshyah SA, Freemantie C, Shahi M, et al. 1995 Replacement therapy with biosynthetic human growth hormone in hypopituitary adults. Clin Endocrinol (Oxf). 42:73-84.
12. Binnerts A, Swart GR, Wilson JHP, et al. 1992 The effects of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on bone metabolism. Clin Endocrinol (Oxf). 37:79-87.
13. Orme SM, Sebastian JP, Oldroyd B, et al. 1992 Comparison of measures of body composition in a trial of low dose growth hormone replacement therapy. Clin Endocrinol (Oxf). 37:453-459.
14. Weaver JU, Monson JP, Noonan K, et al. 1995 The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity, and cardiovascular risk factors in hypopituitary adults. J Clin Endocrinol Metab. 80:153-159.
15. Frantz AG, Rabkin MT. 1965 Effects of estrogen and sex difference on secretion of human growth hormone. J Clin Endocrinol Metab. 25:1470-1480.
16. Ho KY, Evans WS, Blizzard RM, et al. 1987 Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations. J Clin Endocrinol Metab. 64:51-58.
17. Chapman IM, Hartman ML, Straume M, Johnson ML, Veldhuis JD, Thorner MO. 1994 Enhanced sensitivity growth hormone (GH) chemiluminescence assay reveals lower postglucose nadir GH concentrations in men than in women. J Clin Endocrinol Metab. 78:1312-1319.
18. Veldhuis JD. 1996 Gender differences in secretory activity of the human somatotropic (growth hormone) axis. Eur J Endocrinol. 134:287-95.
19. Lang I, Schernthaner G, Pietschmann P, Kurz R, Stephenson JM, Tempi H. 1987 Effects of sex and age on growth hormone response to growth hormone-releasing hormone in healthy individuals. J Clin Endocrinol Metab. 65:535-540.
20. Benito P, Avila L, Corpas MS, et al. 1991 Sex-differences in growth hormone response to growth hormone releasing hormone. J Endocrinol Invest. 14:265-268.
21. Jansson J-O, Edén S, Isaksson O. 1985 Sexual dimorphism in the control of growth hormone secretion. Endocr Rev. 6:128-149.
22. Johansson AG, Forslund A, Sjödin A, Mallmin H, Hambreus L, Ljunghall S. 1993 Determination of body composition-a comparison of dual energy x-ray absorptiometry (DEXA) and hydrodensitymetry. Am J Nutr. 57:323-326.
23. Öberg K, Norheim I, Wide L. 1985 Serum growth hormone in patients with carcinoid tumours; basal levels and response to glucose and thyrotropin releasing hormone. Acta Endocrinol (Copenh). 109:13-18.
24. Friedewald WT, Levy RI, Fredrickson DS. 1972 Estimation of the concentration of lowdensity lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem. 18:499-502.
25. Rosén T, Johannsson G, Hallgren P, Caidahl K, Bosaeus I, Bengtsson B-Å 1994 Beneficial effects of 12 months replacement therapy with recombinant human growth hormone to growth-hormone deficient adults. Endocrinol Metab. 1:55-66.
26. Corpas E, Harman SM, Blackman MR. 1993 Human growth hormone and human ageing. Endocr Rev. 14:20-39.
27. Zadik Z, Stuart ATC, McCarter RJ, Meistas M, Kowarski AA. 1985 The influence of age on the 24-hour integrated concentration of growth hormone in normal individuals. J Clin Endocrinol Metab. 60:513-516.
28. Merimee TJ, Fineberg SE. 1971 Studies of sex based variation of human growth hormone secretion. J Clin Endocrinol Metab. 33:896-902.
29. Juul A, Bang P, Hertel NT, et al. 1994 Serum insulin-like factor-I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index. J Clin Endocrinol Metab. 78:744-752.
30. Clemmons DR, Underwood LE, Ridgay EC, Kliman B, Kjellberg RN, Van Wyk JJ. 1980 Estradiol treatment of acromegaly: reduction of immunoreactive somatomedin C and improvement of metabolic status. Am J Med. 69:571-575.
31. Dawson-Hughes B, Stern D, Goldman J, Reichlin S. 1986 Regulation of growth hormone and somatomedin-C secretion in postmenopausal women: effect of physiological estrogen replacement. J Clin Endocrinol Metab. 63:424-432.
32. Weissberger AJ, Ho KY, Lazarus L. 1991 Contrasting effects of oral and transdermal routes of replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor 1, and GH-binding protein in postmenopausal women. J Clin Endocrinol Metab. 72:374-381.
33. Holloway L, Butterfield G, Hintz RL, Gesundheit N, Marcus R. 1994 Effects of recombinant human growth hormone on metabolic indices, body composition, and bone turnover in healthy elderly women. J Clin Endocrinol Metab. 79:470-479.
34. Zachmann M, Prader A. 1970 Anabolic and androgenic effect of testosterone in sexually immature boys and its dependency on growth hormone. J Clin Endocrinol Metab. 30:85-95.
35. Hobbs CJ, Plymate SR, Rosén CJ, Adler RA. 1993 Testosterone administration increases insulin-like growth factor-I levels in normal men. J Clin Endocrinol Metab. 77:776-779.
36. Holmäng S, Jönsson L, Sjöström L, Holm G, Lindstedt G, Björntorp P. 1992 The effects of testosterone treatment on body composition and metabolism in middle-aged obese men. Int J Obes Relat Metab Disord. 16:991-997.
37. Xu X, de Pergola G, Björntorp P. 1990 The effects of androgen on the regulation of lipolysis in adipose precursor cells. Endocrinology. 126:1229-34.
38. Beauville M, Harant I, Crampes F, Riviere D, Tauber MT, Garrigues M. 1992 Effect of long-term rhGH administration in GH-deficient adults on fat cell epinephrine response. Am J Physiol. 263:E467-E472.
39. Mårin P, Odén P, Björntorp P. 1995 Assimilation and mobilization of triglycerides in subcutaneous abdominal and femoral adipose tissue in vivo in men: effects of androgens. J Clin Endocrinol Metab. 80:239-243.
40. Ottosson M, Vikman-Adolfsson K, Enerbäck S, Elander A, Björntorp P, Edén S. 1995 Growth hormone inhibits lipoprotein lipase activity in human adipose tissue. J Clin Endocrinol Metab. 80:936-941.
41. De Boer H, Blok GJ, Voerman HJ, Philips M, Schouten JA. 1994 Serum lipid levels in growth hormone deficient men. Metabolism. 43:199-203.
42. Dawson S, Henney A. 1992 The status of PAI-1 as a risk factor for arterial and thrombotic disease; a review. Arteriosclerosis. 95:105-117.
43. Johansson JO, Landin K, Tengborn L, Rosen T, Bengtsson BA. 1994 High fibrinogen and plasminogen activator inhibitor activity in growth hormone-deficient adults. Arterioscler Thromb. 14:434-437.
44. Law MR, Wald NJ, Thompson SG. 1994 By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease. Br Med J. 308:367-373.
45. Mbewa AD, Durrington PN. 1990 Lipoprotein(a); structure, properties and possible involvement in the thrombogenesis and atherogenesis. Atherosclerosis. 85:1-14.
46. Berglund L. 1995 Diet and drug theraphy for lipoprotein(a). Curr Opin Lipidol. 6:48-56.
47. De Boer H, Blok G-J, Voerman B, De Vries P, Popp-Snijders C, Van der Veen E. 1995 The optimal growth hormone replacement dose in adults, derived from bioimpedance analysis. J Clin Endocrinol Metab. 80:2069-2076.